Stockscreener 앱 받기
0.845
2.45%
0.0202
시장 영업 전:
.83
-0.015
-1.78%
전일 마감가:
$0.8248
열려 있는:
$0.8157
하루 거래량:
114.87K
Relative Volume:
0.07
시가총액:
$7.35M
수익:
-
순이익/손실:
$-16.42M
주가수익비율:
-0.0362
EPS:
-23.3189
순현금흐름:
$-6.75M
1주 성능:
+11.17%
1개월 성능:
+3.68%
6개월 성능:
+13.93%
1년 성능:
+0.00%
1일 변동 폭
$0.815
$0.8566
1주일 범위
$0.656
$0.914
52주 변동 폭
$0.575
$23.13
Silexion Therapeutics Corp Stock (SLXN) Company Profile
명칭
Silexion Therapeutics Corp
전화
972-8-6286005
주소
12 ABBA HILLEL ROAD, RAMAT GAN
SLXN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLXN
Silexion Therapeutics Corp
|
0.845 | 6.61M | 0 | -16.42M | -6.75M | -23.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Silexion Therapeutics Corp 주식(SLXN)의 최신 뉴스
What analysts say about Silexion Therapeutics Corp stockConsistent wealth multiplication - Autocar Professional
Is Silexion Therapeutics Corp a good long term investmentRapid capital growth - Autocar Professional
What drives Silexion Therapeutics Corp Equity Warrant stock priceHigh-velocity capital appreciation - Autocar Professional
What analysts say about Silexion Therapeutics Corp Equity Warrant stockHigh-return market picks - jammulinksnews.com
Is Silexion Therapeutics Corp Equity Warrant a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com
What drives Silexion Therapeutics Corp stock priceMarket-crushing stock picks - jammulinksnews.com
Why Silexion Therapeutics Corp stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
Silexion Therapeutics Corp Equity Warrant Stock Analysis and ForecastRobust financial gains - Autocar Professional
Silexion Plans Reverse Split to Regain Nasdaq Compliance - TipRanks
Silexion Therapeutics Corp Stock Analysis and ForecastDynamic portfolio growth - jammulinksnews.com
Silexion Therapeutics Announces 1-for-15 Reverse Share Split - The Manila Times
Silexion announces 1-for-15 reverse share split effective July 29 - Investing.com Nigeria
Silexion announces 1-for-15 reverse share split effective July 29 By Investing.com - Investing.com South Africa
SLXN unveils 1-for-15 reverse split to preserve Nasdaq listing | SLXN SEC FilingForm 8-K - Stock Titan
Biotech Silexion Implements 15:1 Reverse Split to Strengthen Position for Cancer Drug Development - Stock Titan
How Silexion Therapeutics Corp stock performs during market volatilityTechnical Breakout List - Newser
What makes Silexion Therapeutics Corp stock price move sharplyFree Stock Market Beginners Guide - Newser
What makes Silexion Therapeutics Corp Equity Warrant stock price move sharplyProven High Yield Signals - Newser
Why Silexion Therapeutics Corp Equity Warrant stock attracts strong analyst attentionVerified Return Tips - Newser
Silexion Therapeutics Corp (SLXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
자본화:
|
볼륨(24시간):